Literature DB >> 10794254

The 30-Hz flicker cone ERG for monitoring the early course of central retinal vein occlusion.

J Larsson1, B Bauer, S Andréasson.   

Abstract

PURPOSE: Investigation of the full-field ERG (electoretinography) within 24 hours after the onset of symptoms in central retinal vein occlusion, and repeated examination within the following days and weeks.
METHODS: Seven patients with central retinal vein occlusion were examined with full-field ERG within less than 24 hours after the onset of their symptoms and every second to third day during the first 3 weeks. They were then followed for a period of time of six months.
RESULTS: The amplitudes as well as the implicit times in the 30 Hz flicker ERG changed considerably within the first three weeks. In the three patients who developed rubeosis, the cone b-wave implicit times as well as the amplitudes were altered considerably. In the patients that did not develop rubeosis, the cone b-wave implicit times as well as the amplitudes in the 30 Hz flicker ERG were more stable.
CONCLUSION: The full-field cone ERG reflects the retinal function and the ERG parameters change considerably during the first weeks after the onset of the central retinal vein occlusion. The 30 Hz flicker ERG gives important information concerning the early development of the disease. The optimal time to do a predictive ERG could be after three weeks.

Entities:  

Mesh:

Year:  2000        PMID: 10794254     DOI: 10.1034/j.1600-0420.2000.078002187.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  20 in total

1.  Wide field multifocal and standard full field electroretinographic features of hemi retinal vein occlusion.

Authors:  Fiona Mary Dolan; Stuart Parks; David Keating; Gordon Neale Dutton
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

2.  The photopic negative response of the flash electroretinogram in retinal vein occlusion.

Authors:  Hongling Chen; Dezheng Wu; Shizhou Huang; Hong Yan
Journal:  Doc Ophthalmol       Date:  2006-08-30       Impact factor: 2.379

3.  The flicker electroretinogram interocular amplitude ratio is a strong prognostic indicator of neovascularization in patients with central retinal vein occlusion.

Authors:  Hsi-Kung Kuo; Ming-Tse Kuo; Yung-Jen Chen; Pei-Chang Wu; Chih-Hsin Chen; Yi-Hao Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-08       Impact factor: 3.117

4.  Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema.

Authors:  Hidetaka Noma; Hideharu Funatsu; Seiyo Harino; Takeshi Sugawara; Tatsuya Mimura; Katsunori Shimada
Journal:  Doc Ophthalmol       Date:  2011-07-30       Impact factor: 2.379

5.  Flicker electroretinograms recorded with mydriasis-free RETeval system before and after cataract surgery.

Authors:  G Miura; E Sato; S Yamamoto
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

6.  Reproducibility of Fixed-luminance and Multi-luminance Flicker Electroretinography in Patients With Diabetic Retinopathy Using an Office-based Testing Paradigm.

Authors:  John J Wroblewski; Christa McChancy; Kassandra Pickel; Hunter Buterbaugh; Tyler Wieland; Alberto Gonzalez
Journal:  J Diabetes Sci Technol       Date:  2019-10-22

7.  Photopic 30 Hz flicker ERG as a predictor for rubeosis in central retinal vein occlusion.

Authors:  J Larsson; S Andréasson
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

8.  Bevacizumab in retinal vein occlusion-results of a prospective case series.

Authors:  Andreas Stahl; Hansjürgen Agostini; Lutz L Hansen; Nicolas Feltgen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-14       Impact factor: 3.117

9.  Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1).

Authors:  Siamak Moradian; Hooshang Faghihi; Babak Sadeghi; Niloofar Piri; Hamid Ahmadieh; Masoud Soheilian; Mohammad Hossein Dehghan; Mohsen Azarmina; Mohammad Riazi Esfahani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-18       Impact factor: 3.117

10.  A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy.

Authors:  April Y Maa; William J Feuer; C Quentin Davis; Ensa K Pillow; Tara D Brown; Rachel M Caywood; Joel E Chasan; Stephen R Fransen
Journal:  J Diabetes Complications       Date:  2015-12-09       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.